Amgen seeks a Senior Scientist for Therapeutic Modality Assessment in Surface Biology. You will triage proteomics/transcriptomics hits to define actionable target properties and guide early modality selection.
You will conduct quantitative surface target characterization and evaluate modalities, informing prioritization strategies. The role requires PhD in cell biology with industry experience, strong data analysis, and hands-on HTS/flow cytometry expertise.
#J-18808-LjbffrSenior Scientist: Surface Target Modality Discovery in thousand oaks at Unknown Company
This position is listed as full time and onsite.